EDIBLE GARDEN AG INC (EDBL)

US28059P3038 - Common Stock

0.1607  -0.01 (-3.54%)

Premarket: 0.1567 0 (-2.49%)

Fundamental Rating

2

EDBL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 91 industry peers in the Food Products industry. EDBL has a bad profitability rating. Also its financial health evaluation is rather negative. EDBL is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

EDBL had negative earnings in the past year.
In the past year EDBL has reported a negative cash flow from operations.

1.2 Ratios

EDBL has a worse Return On Assets (-137.74%) than 95.60% of its industry peers.
EDBL has a worse Return On Equity (-374.59%) than 90.11% of its industry peers.
Industry RankSector Rank
ROA -137.74%
ROE -374.59%
ROIC N/A
ROA(3y)-156.88%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 18.27%, EDBL is in line with its industry, outperforming 45.05% of the companies in the same industry.
EDBL's Gross Margin has declined in the last couple of years.
EDBL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.83%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

EDBL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EDBL has more shares outstanding
The debt/assets ratio for EDBL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -7.33, we must say that EDBL is in the distress zone and has some risk of bankruptcy.
EDBL has a Altman-Z score of -7.33. This is amonst the worse of the industry: EDBL underperforms 90.11% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that EDBL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.23, EDBL is doing good in the industry, outperforming 62.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -7.33
ROIC/WACCN/A
WACC6.39%

2.3 Liquidity

EDBL has a Current Ratio of 1.11. This is a normal value and indicates that EDBL is financially healthy and should not expect problems in meeting its short term obligations.
EDBL has a Current ratio of 1.11. This is in the lower half of the industry: EDBL underperforms 71.43% of its industry peers.
EDBL has a Quick Ratio of 1.11. This is a bad value and indicates that EDBL is not financially healthy enough and could expect problems in meeting its short term obligations.
EDBL has a Quick ratio (0.81) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.81

6

3. Growth

3.1 Past

EDBL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.68%, which is quite impressive.
EDBL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.88%.
EDBL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.17% yearly.
EPS 1Y (TTM)87.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.8%
Revenue 1Y (TTM)7.88%
Revenue growth 3Y14.17%
Revenue growth 5YN/A
Sales Q2Q%-21.46%

3.2 Future

Based on estimates for the next years, EDBL will show a very strong growth in Earnings Per Share. The EPS will grow by 37.10% on average per year.
Based on estimates for the next years, EDBL will show a very strong growth in Revenue. The Revenue will grow by 23.63% on average per year.
EPS Next Y-324.33%
EPS Next 2Y37.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.32%
Revenue Next 2Y23.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EDBL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDBL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EDBL's earnings are expected to grow with 37.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.1%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EDBL!.
Industry RankSector Rank
Dividend Yield N/A

EDIBLE GARDEN AG INC

NASDAQ:EDBL (12/2/2024, 8:00:01 PM)

Premarket: 0.1567 0 (-2.49%)

0.1607

-0.01 (-3.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -137.74%
ROE -374.59%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 0.81
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)87.68%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-324.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.88%
Revenue growth 3Y14.17%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y